187 related articles for article (PubMed ID: 2394005)
1. Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension.
Eisenberg PR; Lucore C; Kaufman L; Sobel BE; Jaffe AS; Rich S
Circulation; 1990 Sep; 82(3):841-7. PubMed ID: 2394005
[TBL] [Abstract][Full Text] [Related]
2. Thrombosis and intrinsic fibrinolysis in percutaneous transluminal angioplasty.
Jørgensen B; Nielsen JD; Helligsø P; Baekgaard N; Egeblad M
Eur J Vasc Surg; 1994 May; 8(3):264-9. PubMed ID: 8013675
[TBL] [Abstract][Full Text] [Related]
3. [Significance of fibrinopeptide A as an indicator for coagulative analysis in thrombotic diseases].
Murakoshi T
Hokkaido Igaku Zasshi; 1982 May; 57(3):351-63. PubMed ID: 6957368
[TBL] [Abstract][Full Text] [Related]
4. Induction of marked thrombin activity by pharmacologic concentrations of plasminogen activators in nonanticoagulated whole blood.
Eisenberg PR; Miletich JP
Thromb Res; 1989 Sep; 55(5):635-43. PubMed ID: 2510363
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of activation of prothrombin by streptokinase compared with urokinase and tissue-type plasminogen activator (t-PA).
Eisenberg PR; Miletich JP; Sobel BE; Jaffe AS
Thromb Res; 1988 Jun; 50(5):707-17. PubMed ID: 3137687
[TBL] [Abstract][Full Text] [Related]
6. Monitoring of fibrin generation during thrombolytic therapy of acute myocardial infarction with recombinant tissue-type plasminogen activator.
Rapold HJ; Kuemmerli H; Weiss M; Baur H; Haeberli A
Circulation; 1989 May; 79(5):980-9. PubMed ID: 2496939
[TBL] [Abstract][Full Text] [Related]
7. Plasma coagulation profiles in patients with severe primary pulmonary hypertension.
Hoeper MM; Sosada M; Fabel H
Eur Respir J; 1998 Dec; 12(6):1446-9. PubMed ID: 9877507
[TBL] [Abstract][Full Text] [Related]
8. The fibrinolytic response to ancrod therapy: characterization of fibrinogen and fibrin degradation products.
Prentice CR; Hampton KK; Grant PJ; Nelson SR; Nieuwenhuizen W; Gaffney PJ
Br J Haematol; 1993 Feb; 83(2):276-81. PubMed ID: 8457476
[TBL] [Abstract][Full Text] [Related]
9. Measurement of fibrinopeptide A in human blood.
Nossel HL; Yudelman I; Canfield RE; Butler VP; Spanondis K; Wilner GD; Qureshi GD
J Clin Invest; 1974 Jul; 54(1):43-53. PubMed ID: 4600045
[TBL] [Abstract][Full Text] [Related]
10. Activation of coagulation and fibrinolytic systems following stroke.
Lane DA; Wolff S; Ireland H; Gawel M; Foadi M
Br J Haematol; 1983 Apr; 53(4):655-8. PubMed ID: 6219694
[TBL] [Abstract][Full Text] [Related]
11. Fibrinopeptide A during normal pregnancy.
Romero R; Rickles FR; Matthews E; Scott D; Dinan C; Duffy T
Am J Perinatol; 1988 Jan; 5(1):70-3. PubMed ID: 3257391
[TBL] [Abstract][Full Text] [Related]
12. Fibrin metabolism in patients with acute myocardial infarction during and after treatment with tissue-type plasminogen activator.
Ring ME; Butman SM; Bruck DC; Feinberg WM; Corrigan JJ
Thromb Haemost; 1988 Dec; 60(3):428-33. PubMed ID: 2976994
[TBL] [Abstract][Full Text] [Related]
13. Fibrinopeptide A and B beta 15-42 in liver cirrhosis.
Marongiu F; Mameli G; Acca MR; Mulas G; Medda A; Tronci MB; Mamusa AM; Balestrieri A
Haemostasis; 1988; 18(2):126-8. PubMed ID: 2457543
[TBL] [Abstract][Full Text] [Related]
14. The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity.
Nossel HL; Ti M; Kaplan KL; Spanondis K; Soland T; Butler VP
J Clin Invest; 1976 Nov; 58(5):1136-44. PubMed ID: 993337
[TBL] [Abstract][Full Text] [Related]
15. Fibrin degradation products generation and fibrinopeptide A release in normal plasma incubated with thrombolytic agents: proposed mechanisms.
Mirshahi M; Soria J; Bertrand O; Amiral J; Soria C
Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):531-6. PubMed ID: 1723308
[TBL] [Abstract][Full Text] [Related]
16. Thrombin binds to soluble fibrin degradation products where it is protected from inhibition by heparin-antithrombin but susceptible to inactivation by antithrombin-independent inhibitors.
Weitz JI; Leslie B; Hudoba M
Circulation; 1998 Feb; 97(6):544-52. PubMed ID: 9494024
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 125I-fibrinogen kinetics and fibrinopeptide A in patients with disseminated neoplasias.
Mombelli G; Roux A; Haeberli A; Straub PW
Blood; 1982 Aug; 60(2):381-8. PubMed ID: 7093524
[TBL] [Abstract][Full Text] [Related]
18. Fibrinogen and fibrin derivatives in traumatized patients: relation to injury severity and posttraumatic pulmonary dysfunction.
Sørensen JV; Jensen HP; Rahr HB; Borris LC; Lassen MR; Fedders O; Haase JP; Knudsen F
Haemostasis; 1993; 23(2):91-7. PubMed ID: 8365691
[TBL] [Abstract][Full Text] [Related]
19. In vivo measurements of fibrin formation and fibrinolysis in operable breast cancer.
McCulloch P; Douglas J; Lowe GD; Murray G; George WD
Thromb Haemost; 1989 Apr; 61(2):318-21. PubMed ID: 2749603
[TBL] [Abstract][Full Text] [Related]
20. [Long-term hemodialysis and changes in variables of coagulation and fibrinolysis].
Uchida Y
Fukuoka Igaku Zasshi; 1991 Nov; 82(11):576-85. PubMed ID: 1774013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
